LMO2 and acute lymphoblastic leukemia: The striking similarities between CD2-Lmo2 transgenic T-ALLs and human T-ALL suggest that these transgenic mice are a compelling mouse model of human disease, one that will prove useful in studying a highly treatment-resistant leukemia.